ED
CADE

Exane Derivatives’s Cadence Bancorporation CADE Stock Holding History

Exane Derivatives’s Portfolio CADE Stock Details CADE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$132 – 1129
2021
Q3 		$132 Hold
6
– – ﹤0.01% 1021
2021
Q2 		$119 Sell
6
-2,349
-100% -$51.5K ﹤0.01% 1026
2021
Q1 		$48.8K Buy
+2,355
New +$47.9K 0.01% 519

Other funds holding CADE

GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
EM
ELCO Management New York $232M AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Exane Derivatives's CADE Position: Q4 2021 in Review

Exane Derivatives sold out of Cadence Bancorporation (CADE) in Q4 2021, closing a stake of 6 shares — an estimated $132 sold.

Exane Derivatives first reported a position in CADE in Q1 2021 and held it in 3 quarters. The position peaked at $48.8K in Q1 2021. 4 funds tracked by Wall St. Rank hold CADE as of Q4 2021.

  • Exane Derivatives reported no remaining Cadence Bancorporation position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 6 Cadence Bancorporation shares in Q4 2021, an estimated $132.
  • Exane Derivatives first reported a position in Cadence Bancorporation in Q1 2021 and held it in 3 quarters.
  • Exane Derivatives's Cadence Bancorporation position peaked at $48.8K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Cadence Bancorporation as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.